National Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement Post author:GHIAA Admin Post published:March 2, 2023 Post category: Continue ReadingNational Health Service (NHS) – Pfizer/Shionogi, Antibiotic Supply Agreement
DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement Post author:GHIAA Admin Post published:October 26, 2022 Post category: Continue ReadingDNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
Wellcome Trust – PTC Therapeutics, Cancer Treatment Research Funding Agreement Post author:GHIAA Admin Post published:October 25, 2022 Post category: Continue ReadingWellcome Trust – PTC Therapeutics, Cancer Treatment Research Funding Agreement
AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement Post author:GHIAA Admin Post published:September 13, 2022 Post category: Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement
Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement Post author:GHIAA Admin Post published:September 6, 2022 Post category: Continue ReadingAlnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
Shionogi – GARDP, Cefiderocol License Agreement Post author:GHIAA Admin Post published:July 7, 2022 Post category: Continue ReadingShionogi – GARDP, Cefiderocol License Agreement
NIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement
DNDi/GARDP – Entasis, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingDNDi/GARDP – Entasis, Gonorrhoea Medication, Collaboration Agreement
Gates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingGates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement